1. Home
  2. THFF vs PHAR Comparison

THFF vs PHAR Comparison

Compare THFF & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Financial Corporation Indiana

THFF

First Financial Corporation Indiana

HOLD

Current Price

$76.04

Market Cap

930.9M

Sector

Finance

ML Signal

HOLD

Logo Pharming Group N.V.

PHAR

Pharming Group N.V.

HOLD

Current Price

$10.92

Market Cap

793.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
THFF
PHAR
Founded
1984
1988
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
930.9M
793.4M
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
THFF
PHAR
Price
$76.04
$10.92
Analyst Decision
Hold
Strong Buy
Analyst Count
2
3
Target Price
$62.00
$38.33
AVG Volume (30 Days)
86.1K
17.0K
Earning Date
04-28-2026
05-07-2026
Dividend Yield
3.46%
N/A
EPS Growth
67.00
N/A
EPS
3.58
N/A
Revenue
N/A
N/A
Revenue This Year
$17.88
$10.04
Revenue Next Year
$4.03
$2.51
P/E Ratio
$21.53
$3,041.22
Revenue Growth
N/A
N/A
52 Week Low
$51.21
$9.62
52 Week High
$84.17
$21.34

Technical Indicators

Market Signals
Indicator
THFF
PHAR
Relative Strength Index (RSI) 35.09 40.01
Support Level $74.32 $9.62
Resistance Level $78.57 $13.51
Average True Range (ATR) 1.75 0.38
MACD -0.26 -0.04
Stochastic Oscillator 23.28 12.79

Price Performance

Historical Comparison
THFF
PHAR

About THFF First Financial Corporation Indiana

First Financial Corp operates as a financial holding company, which is engaged in the provision of financial services in the United States. The company offers a wide variety of financial services including commercial, mortgage, and consumer lending, lease financing, trust account services, depositor services and insurance services, through its subsidiaries. Its primary source of revenue is derived from loans to customers and investment activities. Company's loan portfolio was diversified in Commercial, Residential and consumer domains.

About PHAR Pharming Group N.V.

Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.

Share on Social Networks: